BIG
GILD icon

Brookwood Investment Group’s Gilead Sciences GILD Stock Holding History

Brookwood Investment Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,261
Closed -$646K – 544
2025
Q4 		$646K Sell
5,261
-875
-14% -$106K 0.08% 237
2025
Q3 		$681K Buy
+6,136
New +$697K 0.09% 209
2025
Q2 		– Sell
-6,723
Closed -$753K – 482
2025
Q1 		$753K Buy
+6,723
New +$694K 0.13% 160

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Brookwood Investment Group's GILD Position: Q1 2026 in Review

Brookwood Investment Group sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 5,261 shares — an estimated $646K sold.

Brookwood Investment Group first reported a position in GILD in Q1 2025 and held it in 3 quarters. The position peaked at $753K in Q1 2025. 2,320 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Brookwood Investment Group reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
  • Brookwood Investment Group sold 5,261 Gilead Sciences shares in Q1 2026, an estimated $646K.
  • Brookwood Investment Group first reported a position in Gilead Sciences in Q1 2025 and held it in 3 quarters.
  • Brookwood Investment Group's Gilead Sciences position peaked at $753K in Q1 2025.
  • 2,320 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Brookwood Investment Group's 13F filing for Q1 2026, filed 4 May 2026.